Publicacións en colaboración con investigadores/as de Universidad Complutense de Madrid (18)

2024

  1. Longitudinal changes in the functional connectivity of individuals at risk of Alzheimer’s disease

    GeroScience, Vol. 46, Núm. 3, pp. 2989-3003

  2. Minimum spanning tree analysis of unimpaired individuals at risk of Alzheimer's disease

    Brain Communications, Vol. 6, Núm. 5

2022

  1. Efficacy of the Therapeutic Game “Trisquel” in the Treatment of Patients With Substance-Related Disorders Randomized Clinical Study

    Frontiers in Psychiatry, Vol. 13

2021

  1. Humanization in mental health plans in Spain

    Revista de Psiquiatria y Salud Mental

  2. Important role of microglia in HIV-1 associated neurocognitive disorders and the molecular pathways implicated in its pathogenesis

    Annals of Medicine, Vol. 53, Núm. 1, pp. 43-69

  3. Microglia: The real foe in hiv-1-associated neurocognitive disorders?

    Biomedicines, Vol. 9, Núm. 8

  4. Premorbid Characteristics as Predictors of Early Onset Versus Adult Onset in Patients with a First Episode of Psychosis

    Journal of Clinical Psychiatry, Vol. 82, Núm. 6

  5. The role of dopamine receptors in lymphocytes and their changes in schizophrenia

    Brain, Behavior, and Immunity - Health, Vol. 12

2020

  1. Efectividad del programa de intervención «El Trisquel» en personas con trastornos del espectro de la esquizofrenia

    Actas Espanolas de Psiquiatria, Vol. 48, Núm. 5, pp. 209-219

2019

  1. CIBERSAM: Ten years of collaborative translational research in mental disorders

    Revista de Psiquiatria y Salud Mental, Vol. 12, Núm. 1, pp. 1-8

  2. Long-acting injectable antipsychotics for the treatment of schizophrenia in Spain

    Revista de Psiquiatria y Salud Mental, Vol. 12, Núm. 2, pp. 92-105

2015

  1. Clinical and economic outcomes of adjunctive therapy with pregabalin or usual care in generalized anxiety disorder patients with partial response to selective serotonin reuptake inhibitors

    Annals of General Psychiatry, Vol. 14, Núm. 1

  2. Pregabalin for the treatment of patients with generalized anxiety disorder with inadequate treatment response to antidepressants and severe depressive symptoms

    International Clinical Psychopharmacology, Vol. 30, Núm. 5, pp. 265-271

2013

  1. A comparative cost-analysis of initiating pregabalin or SSRI/SNRI therapy in benzodiazepine-resistant patients with generalized anxiety disorder in Spain

    Actas Espanolas de Psiquiatria, Vol. 41, Núm. 3, pp. 164-174

2012

  1. Prolonged oral cannabinoid administration prevents neuroinflammation, lowers β-amyloid levels and improves cognitive performance in Tg APP 2576 mice

    Journal of Neuroinflammation, Vol. 9

2008

  1. Megalin mediates the transport of leptin across the blood-CSF barrier

    Neurobiology of Aging, Vol. 29, Núm. 6, pp. 902-912

2004

  1. Diferencias clínicas en la depresión según la clase social

    Anales de Psiquiatria, Vol. 20, Núm. 10, pp. 413-421

2001

  1. Disociación y discordancia

    Setenta y cinco años de historia de la psiquiatría (1924-1999): III Jornadas Nacionales de Historia de la Psiquiatría. 75 años de Historia de la AEN